IR Press

PTA-News: Hoenle AG: Sales stabilised, earnings improved after nine months

Gilching (pta008/18.08.2026/08:30) – * Hoenle Group realises sales of € 69.0 million (-1.1%) after nine months * Reluctance to invest in mechanical and plant engineering weighs on Curing Business Unit * Efficiency measures and focus on profitable business areas are having an effect * Sales and earnings increase in the Adhesive Systems and Disinfection Business Units * Group EBITDA climbs from € 3.6 million in the previous year to € 4.5 million in FY 2025/26

PTA-News: Hoenle AG: Hoenle posts surge in earnings in the second quarter; forecast confirmed

Gilching (pta014/19.05.2026/08:40) – * Hoenle Group achieves sales of EUR 45.3 million (-3.9%) in the first half of the financial year * Reluctance to invest in mechanical and plant engineering weighs on Curing business unit * Gross profit of EUR 30.0 million (+0.1%) at previous year’s level * EBITDA of EUR 2.7 million (-9.5%) * Management Board confirms outlook for financial year 2025/26

PTA-News: Hoenle AG: Revenues of EUR 21.5 million in Q1 at the previous year’s level

Gilching (pta009/24.02.2026/08:10) – * Hoenle Group starts with sales of EUR 21.5 million (+0,3%) in the first quarter of the financial year 2025/26 * Weakness in mechanical and plant engineering impacts business development of the Curing Business Unit * Strong business development with water disinfection systems leads to increasing sales and earnings contributions in the Disinfection Business Unit * Based on innovation projects, the expansion of the after-sales business and strict cost management, a significant business recovery and improvement in earnings is expected in the second half of the financial year * Management Board confirms guidance for financial year 2025/26

PTA-Adhoc: Hoenle AG: Dr. Franz Richter appointed to the Management Board of Hoenle AG for three years

Gilching (pta024/02.02.2026/17:50) – On October 1, 2025, the Supervisory Board of Hoenle AG appointed Dr. Franz Richter to the Management Board of Hoenle AG, where he assumed the role of CEO. His position on the Supervisory Board has been suspended since then. Franz Richter has now been appointed to the Management Board of Hoenle AG for a three-year term, where he will assume the chairmanship. His contract as CEO runs until February 28, 2029. Franz Richter will resign from his position on the Supervisory Board on February 28, 2026.

PTA-News: Hoenle AG: Hoenle Group improved its operating profit before depreciation to EUR 5.8 million in the 2024/25 financial year

Gilching (pta004/08.12.2025/08:00) – * A weak market environment and reorganization measures led to a decline in revenue from EUR 98.7 million to EUR 93.7 million * Despite the decline in revenue, operating profit before depreciation (EBITDA) improved from EUR 3.0 million (adjusted EUR 5.5 million) to EUR 5.8 million * Figures are therefore in the upper range of the most recently communicated guidance * Revenue and earnings are expected to increase moderately in the new fiscal year

PTA-News: Dr. Hönle AG: Dr. Franz Richter replaces Dr. Markus Arendt on the Management Board of Hoenle AG

Gilching (pta008/14.09.2025/12:10) – Effective at the end of 14 September 2025, Dr. Markus Arendt will be removed from the Management Board of Hoenle AG. The Supervisory Board of Hoenle AG is appointing Dr. Franz Richter, who currently serves as Chairman of the Supervisory Board of Hoenle AG, to the Management Board as his successor with effect from 1 October 2025. During this period, his Supervisory Board mandate will be suspended.

Scroll to Top